Anacor Pharmaceuticals Obtains $50,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=947b6ce8-95c9-4853-817f-c487ea91b736&Preview=1
Date
1/6/2009
Company Name
Anacor Pharmaceuticals
Mailing Address
1020 East Meadow Circle Palo Alto, CA 94303-4230
Company Description
Anacor is developing novel pharmaceuticals for a variety of inflammatory and infectious diseases based on its proprietary, small-molecule, boron-based chemistry.
Website
http://www.anacor.com
Transaction Type
Venture Equity
Transaction Amount
$50,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to further develop Anacor’s product pipeline based on its boron chemistry platform.
M&A Terms
Venture Investor
GlaxoSmithKline
Venture Investor
Rho Ventures
Venture Investor
Venrock
Venture Investor
Care Capital
Venture Investor
Aberdare Ventures
Venture Investor
Undisclosed